{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:04:54Z","timestamp":1784275494933,"version":"3.55.0"},"reference-count":28,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In France, HIV prevention measures including HIV testing, treatment, and uptake of pre-exposure prophylaxis (PrEP), have increased throughout the last decade. To analyse their impact, we performed a time series analysis of monthly HIV diagnoses reported via the national HIV surveillance database. In addition, we compared the timing of HIV promotional campaigns with monthly trends in HIV testing and PrEP initiation. From January 2012 to December 2022, new HIV diagnoses steadily decreased among men who have sex with men (MSM) born in France and heterosexuals born in France, whereas HIV diagnoses increased among MSM born abroad. HIV testing activity and PrEP use in France both steadily increased from 2014 to 2020, during which multiple campaigns targeting HIV testing and prevention occurred. The decline in HIV diagnoses among MSM born in France preceded the introduction of PrEP in 2016 and continued post-2016 without any acceleration in the rate of decline. Increased awareness of, access to and uptake of HIV prevention measures remain essential to progress towards HIV elimination in France, especially among MSM born abroad.<\/jats:p>","DOI":"10.1017\/s0950268825100976","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T11:30:32Z","timestamp":1767785432000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":1,"title":["Time series analysis of new HIV diagnoses in France from 2012 to 2022"],"prefix":"10.1017","volume":"154","author":[{"given":"David","family":"Kelly","sequence":"first","affiliation":[{"name":"Sant\u00e9 publique France"},{"name":"ECDC Fellowship Programme, Field Epidemiology path (EPIET), ECDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8376-4713","authenticated-orcid":false,"given":"Amber","family":"Kunkel","sequence":"additional","affiliation":[{"name":"HIV, STI and Viral Hepatitis Unit, Sant\u00e9 publique France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauriane","family":"Ramalli","sequence":"additional","affiliation":[{"name":"Sant\u00e9 publique France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mercier","sequence":"additional","affiliation":[{"name":"Sexual Health Unit, Sant\u00e9 publique France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Lot","sequence":"additional","affiliation":[{"name":"HIV, STI and Viral Hepatitis Unit, Sant\u00e9 publique France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Cazein","sequence":"additional","affiliation":[{"name":"HIV, STI and Viral Hepatitis Unit, Sant\u00e9 publique France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"S0950268825100976_r13","article-title":"HIV diagnoses among people born in Ukraine reported by EU\/EEA countries in 2022: Impact on regional HIV trends and implications for healthcare planning","volume":"28","author":"Reyes-Urue\u00f1a","year":"2023","journal-title":"Euro Surveillance"},{"key":"S0950268825100976_r17","article-title":"High proportion of post-migration HIV acquisition in migrant men who have sex with men receiving HIV care in the Paris region, and associations with social disadvantage and sexual behaviours: Results of the ANRS-MIE GANYMEDE study, France, 2021 to 2022","volume":"29","author":"Palich","year":"2024","journal-title":"Euro Surveillance"},{"key":"S0950268825100976_r23","unstructured":"[23] European Centre for Disease Prevention and Control (2024) Pre-exposure prophylaxis for HIV prevention in Europe and Central Asia Monitoring implementation of the Dublin Declaration \u2013 2023 progress report."},{"key":"S0950268825100976_r1","unstructured":"[1] European Centre for Disease Prevention and Control (2023) WHO Europe Region,. HIV\/AIDS surveillance in Europe. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/hivaids-surveillance-europe-2023-2022-data."},{"key":"S0950268825100976_r8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4"},{"key":"S0950268825100976_r4","unstructured":"[4] Sant\u00e9 publique France (2024) VIH et IST bact\u00e9riennes en France. Bilan 2023. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/infections-sexuellement-transmissibles\/vih-sida\/documents\/bulletin-national\/vih-et-ist-bacteriennes-en-france.-bilan-2023#:~:text=Le%20nombre%20de%20personnes%20ayant,forte%20baisse%20observ%C3%A9e%20en%202020."},{"key":"S0950268825100976_r3","unstructured":"[3] Sant\u00e9 publique France (2023) Bulletin de sant\u00e9 publique VIH-IST. Novembre 2023. Annexe 2. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/infections-sexuellement-transmissibles\/vih-sida\/documents\/bulletin-national\/bulletin-de-sante-publique-vih-ist.-novembre-2023."},{"key":"S0950268825100976_r18","article-title":"Minist\u00e8re des affaires sociales et de la Sant\u00e9, Conseil national du Sida, Agence nationale de recherches Sur le sida et les h\u00e9patites virales","author":"Morlat","journal-title":"Prise en charge m\u00e9dicale des personnes vivant avec le VIH Recommandations du groupe d\u2019experts Rapport 2013"},{"key":"S0950268825100976_r7","doi-asserted-by":"publisher","DOI":"10.1016\/S0261-3794(99)00028-1"},{"key":"S0950268825100976_r16","unstructured":"[16] Conseil national du sida et des h\u00e9patites virales (2021) Avis sur la place de la PrEP dans la pr\u00e9vention du VIH en France: changer de paradigme, changer d\u2019\u00e9chelle online: CNS. https:\/\/cns.sante.fr\/wp-content\/uploads\/2021\/05\/2021-04-15_avis_fr_prevention.pdf."},{"key":"S0950268825100976_r19","unstructured":"[19] Epi-Phare Epid\u00e9miologie de produits de sant\u00e9. Suivi de l\u2019utilisation de la prophylaxie pr\u00e9-exposition (PrEP) au VIH 2023. https:\/\/www.epi-phare.fr\/rapports-detudes-et-publications\/prep-vih-2023\/."},{"key":"S0950268825100976_r25","first-page":"430","article-title":"Trends in HIV protection methods among HIV-negative men who have sex with men: Results from the Rapport au sexe survey 2017-2019-2021, France","author":"Velter","year":"2022","journal-title":"Bulletin Epid\u00e9miologique Hebdomadaire"},{"key":"S0950268825100976_r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100486"},{"key":"S0950268825100976_r5","first-page":"456","article-title":"HIV and bacterial sexually transmitted infections screening in France, 2014-2021","volume":"2022","author":"Kounta","year":"2022","journal-title":"Bulletin Epid\u00e9miologique Hebdomadaire"},{"key":"S0950268825100976_r11","unstructured":"[11] Health Protection Surveillance Centre Ireland (2022) HIV in Ireland: Latest trends to end 2022. https:\/\/www.hpsc.ie\/a-z\/hivandaids\/hivdataandreports\/HIV_trends_to%20end%202022_final.pdf."},{"key":"S0950268825100976_r20","first-page":"542","article-title":"HIV Pre-exposure prophylaxis among men who have sex with men responding to the Rapport au Sexe 2023 survey: Who is eligible? Who are the users?","volume":"2023","author":"Velter","year":"2023","journal-title":"Bulletin Epid\u00e9miologique Hebdomadaire"},{"key":"S0950268825100976_r28","article-title":"A 95% decline in estimated newly acquired HIV infections, Amsterdam, 2010 to 2022","volume":"28","year":"2023","journal-title":"Euro Surveillance"},{"key":"S0950268825100976_r14","first-page":"S1","article-title":"Etude de la pr\u00e9valence de l\u2019infection \u00e0 VIH et des h\u00e9patites virales B et C, et chez les migrants r\u00e9guliers en France: Donn\u00e9es de l\u2019\u00e9tude STRADA (2017-2020)","volume":"7622","author":"Duracinsky","year":"2022","journal-title":"M\u00e9decine et Maladies Infectieuse Formation."},{"key":"S0950268825100976_r22","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(22)00106-2"},{"key":"S0950268825100976_r24","first-page":"585","article-title":"Roll-out and effectiveness of HIV pre-exposure prophylaxis in France: An overview","volume":"78","author":"Billioti de Gage","year":"2023","journal-title":"Th\u00e9rapie"},{"key":"S0950268825100976_r10","unstructured":"[10] Stichting HIV Monitoring (2023) Human Immunodeficiency Virus (HIV) Infection in the Netherlands. Monitoring Report 2023. https:\/\/www.hiv-monitoring.nl\/application\/files\/1417\/0229\/8520\/SHM_HIV_MONITORING_REPORT_NL_2023.pdf."},{"key":"S0950268825100976_r15","article-title":"La PrEP chez les migrants : y sommes-nous vraiment ?","volume":"2022","author":"Cordel","year":"2022","journal-title":"Bulletin Epid\u00e9miologique Hebdomadaire"},{"key":"S0950268825100976_r6","unstructured":"[6] Epi-Phare Edpds (2023) Suivi de l\u2019utilisation de la prophylaxie pr\u00e9-exposition (PrEP) au VIH 2023. https:\/\/www.epi-phare.fr\/rapports-detudes-et-publications\/prep-vih-2023\/."},{"key":"S0950268825100976_r9","unstructured":"[9] Robert Koch Institut Germany (2023) Epidemiologisches Bulletin 47\/2023. https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2023\/Ausgaben\/47_23.pdf?__blob=publicationFile."},{"key":"S0950268825100976_r12","article-title":"Changes in the profile of newly HIV-diagnosed men who have sex with men, Madrid, 2014 to 2019","volume":"26","author":"Ayerdi Aguirrebengoa","year":"2021","journal-title":"Euro Surveillance"},{"key":"S0950268825100976_r21","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003012"},{"key":"S0950268825100976_r26","unstructured":"[26] Velter, A. (2024) Evolution de la couverture pr\u00e9ventive contre le VIH en France parmi les hommes ayant des relations sexuelles avec les hommes: Enqu\u00eate rapport au sexe 2017-2019-2021-2023. Journ\u00e9es th\u00e9matiques IST, PrEP, sant\u00e9 sexuelle 2024; Paris2024."},{"key":"S0950268825100976_r27","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002790"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268825100976","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:14:51Z","timestamp":1784272491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268825100976\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":28,"alternative-id":["S0950268825100976"],"URL":"https:\/\/doi.org\/10.1017\/s0950268825100976","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"\u00a9 The Author(s), 2026. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e18"}}